Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.

EMBO J · 2020 · PMC7073464 · PMID 32009247

Europe PMC DOI

hedged sentence

0.0010

closest p · 0.0× alpha

0.0010

boldest claim

The sentences

highly significantP < 0.001actually significant

Differential treatment of cancer organoids over 2 passages clearly showed that addition of these Wnt agonists to OCM resulted in a highly significant ( P < 0.001) inhibition of organoid growth, an effect confirmed for all five OC organoid lines tested (Fig 5 C).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.